#Events | ??Over the last two days, our Business Analyst Camilla Nicolotti attended the Festival of Italian Creativity in #Boston – a vibrant event organised by the Consulate General of Italy and aimed at promoting #Italiancreativity in its various expressions and strengthening ties between Italy and the Boston ecosystem. Panels focused on #Science, #Technology and #Business topics, bringing together leading scientists, entrepreneurs and investors from either ????Boston or ????Italy, alongside local government institutions. ??Additionally, numerous Italian #universities and #researchcentres engaged in interactive discussions, where they had the opportunity to present their centres of expertise and their partnerships with the USA, showcasing their creative and innovative potential. Fondazione LINKS was one of them, highlighting its relationship with #LIFTT. Key takeaways:? ?? Great network of Italian seasoned and fresh talents, along with innovation hotspots led by established industry players; ??Top local experts and investors already leveraging Italian innovation in various fields; ??Italian excellence celebrated abroad, spans from biotech to cleantech, passing through biomaterials; ??Local state and private organizations, as well as Italian institutions, are actively working to foster collaboration between Italy and the US. ??Huge thanks and?congratulations?to all the incredible people who attended the Festival and made the event possible! #FestivalofItalianCreativity #creativity #innovation #Technology #Science #Business #USA
LIFTT
风险投资与私募股权管理人
Torino,Piemonte 10,064 位关注者
An operating Venture Capital, chaired by Stefano Buono, eager to create a bridge between innovative ideas and capital.
关于我们
Chaired by the scientist and entrepreneur Stefano Buono, LIFTT came to life as an operating company in 2019 thanks to Compagnia di San Paolo, Politecnico di Torino and LINKS Foundation. The aim is to encourage technology development and transfer from University to Industry, but also to clear the way from a simple business idea to the creation of an innovative product, offering a dynamic and modern vision of venture capital as applied to Technology Transfer. LIFTT guarantees high visibility to ideas and new businesses at a national and international level, investing and attracting capital and ensuring maximum impact on the local and national territory. While generating value for its shareholders, LIFTT supports the creation of businesses, development, employment and economic growth, through the implementation of an ethical and transparent governance model, based on the participation of all the actors involved.
- 网站
-
https://www.liftt.com
LIFTT的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 11-50 人
- 总部
- Torino,Piemonte
- 类型
- 私人持股
- 创立
- 2019
地点
LIFTT员工
动态
-
#LIFTTPortfolio | ?? Siamo felici di condividere la bellissima intervista di StartupItalia ad Alessandro Taini, in cui si racconta la nascita della nostra #portfoliostartup T1 Solutions | Società Benefit. ?? T1 Solutions nasce da un’idea innovativa e da un incontro fortunato. Giuseppe Peroni, ex chimico, aveva progettato anni fa una #spugna in grado di assorbire sostanze inquinanti, ma il progetto era rimasto incompiuto. Nel 2014, Alessandro Taini ha raccolto questa intuizione trasformandola in #FoamFlex, una spugna che respinge l'acqua e assorbe fino a 25 volte il proprio peso in oli e idrocarburi. ?Peroni voleva lasciare qualcosa per contribuire a salvare il mondo. è un progetto nato grazie ad un'amicizia? racconta Alessandro. ?? Oggi, la startup #cleantech offre i suoi #WaterCleaningKit per affrontare #emergenzeambientali in decine di porti italiani e recentemente ha collaborato con Q8 al progetto Q8 Sailing for Change. Grazie StartupItalia per l'approfondimento! #Innovation #Sustainability #FoamFlex #CleanWater #SaveThePlanet Alessandro Di Stefano Francesco Lo Cascio Guido Panizza
-
#LIFTTportfolio | We are thrilled to announce that our #portofoliostartup Cellply has been selected as one of three Italian startups to join the EIC Scaling Club, the exclusive community that brings together the 120+ most promising #deeptech #scaleups in Europe. ??? This recognition marks an important milestone for Cellply, as it confirms the value of its breakthrough technology, which has the potential to revolutionise cellular cancer therapy and change the lives of thousands of patients. As part of this community, Cellply will have the opportunity to access valuable assets, including funding assistance, leadership mentoring, corporate partnerships and much more, all of which will help fuel the company’s growth. ?? Congratulations?to the Cellply’s team for this incredibile achievement! We are proud to support you on this journey and we strongly believe in your game-changing solutions that will transform the cell and gene therapy field. Well done! Teresa De Nadai Guido Panizza #EICScalingClub #EUeic #DeepTech #Biotech #CellTherapy #CancerTreatment
-
#LIFTTportfolio | “It has been four years since we joined mediaire’s innovative journey, and this new investment further confirms our trust and belief in their commitment to developing ground-breaking solutions that will completely transform the radiology sector". Teresa De Nadai, #LIFTT’s Project Manager commented in regard to the European €12 million investment to fuel #mediaire’s global growth.?"I have always been inspired by Mediaire’s efforts to drive technological innovation in #radiology, and I am proud to support their vision, which has the potential to dramatically improve traditional diagnostic techniques and have a significant impact on the everyday lives of thousands of patients.” “Our #AI solutions are not a futuristic dream. We have already created a reality that is helping doctors make better decisions and giving patients faster answers,” said Dr. Andreas Lemke, CEO, and co-founder of #mediaire. “We are seeing the impact on thousands of radiologists every day in hundreds of hospitals and radiology practices across Europe that are utilizing our AI solutions. With this investment, we will be able to scale these benefits to even more healthcare providers.” #healthcare #medtech #investors #innovation #startups #venturecapital #hospitals #medicalimaging #seeingwhatmatters
-
#LIFTTportfolio | ?? We are proud to announce that our #portfoliostartup, mediaire, has secured a €12 million financing round, led by LBO France, with participation from IBB Ventures and Wille Finance, and supported by existing investors HTGF | High-Tech Gründerfonds, #LIFTT, and Gateway Partners Ventures. ?? mediaire will use the funds to expand its #AI portfolio beyond brain, prostate, and knee diagnostics in magnetic resonance imaging (MRI), and to extend the benefits of its solutions, which include reduced medical workload and improved patient outcomes, on a global scale. ?? This investment allows mediaire's team to broaden their impact ?? ??AI power in every scan. ??Confidence in every diagnosis. ??Efficiency that reaches every patient. ???Congratulations to the entire #mediaire team for this outstanding achievement, let’s keep pushing the boundaries of what #AI can achieve in #radiology. #Healthcare #Radiology #MRI #AI #Scanning #Diagnostics Teresa De Nadai Francesca Mongardi Guido Panizza
Venture capital, nuovo round per la tedesca Mediaire: tra gli investitori anche la società di Stefano Buono (Newcleo) | MilanoFinanza News
milanofinanza.it
-
#LIFTTportfolio | Happy to share that our #portofliostartup BetaGlue Therapeutics has been featured among the 8 most promising startups in #Healthcare and #Biotech by Milano Finanza. To find out more read the article below ?? #Healthcare #Biotech #Radiotherapy #CancerTreatment Francesca Mongardi Guido Panizza
Salute, otto startup che ci faranno bene | MilanoFinanza News
milanofinanza.it
-
LIFTT转发了
Deeptech VC Investments: A Must-Have Conversation at the 0100 Conference Mediterranean! ?? At our VC stream, we hosted an insightful panel discussing how technology shapes the industry. This session covered the latest transformative technologies, from AI and Machine Learning to Quantum Computing and Blockchain. We were thrilled to bring together industry leaders such as: Maria Cristina Odasso, Head of Business Analysis at LIFTT Stephan Wirries, Partner at Ventech Alexander Vaselek, CEO at CIMEDO GmbH Dr. Moritz Belling, Principal at Earlybird Venture Capital Moderated by: Rocio Pillado, Partner at Adara Ventures #Deeptech #VentureCapital #AI
-
#Events | In the last few days we had the pleasure of sponsoring for the second year?the amazing Zero One Hundred Conferences Mediterranean. Our Head of Business Analysis, Maria Cristina Odasso, had the pleasure to share the main stage in the #DeepTech VC Investment panel and to talk about the main challenges deeptech #startups have to face and the vital role of universities, research institutes and investors in shaping a thriving deeptech #ecosystem. With the presence of over 700 #industryleaders, 500 LPs and GPs, 130 #speakers from 50 different #nationalities, the conference was a great opportunity for #LIFTT to meet and connect with top investors and industry experts from across Europe, MENA and North America. Huge thanks to Mauro Marconi and all the 0100 Conference team for this great experience and for the excellent organisation! #0100Conferences #VentureCapital #TechTransfer #Innovation
-
#NewInvestment | X-Therma Inc. is pioneering breakthrough cold chain technology via a convergent biopreservation platform, to advance regenerative medicine and make available safe and on-demand organs, engineered tissues, cell and gene therapies, vaccines, and beyond to patients in need. Let's dive deeper into our last investment.
-
#NewInvestment ?? | We are excited to announce our latest investment in X-Therma Inc., a pioneering #biotechnology company developing a breakthrough #biopreservation platform for #regenerative medicine and #organtransplantation. Using their innovative XT-ViVo? solution and TimeSeal? device, X-Therma successfully transported pig kidneys across the Atlantic five times, preserving them at subzero temperatures for up to #72 hours—without the use of ice. This world-first achievement has the potential to transform organ transplantation by dramatically extending preservation times and enabling long-distance transport, helping to bridge the organ supply-demand gap and improve transplant outcomes. By eliminating the limitations of ice-based preservation, this technology could reduce emergency surgeries, enhance genetic matching, and save countless lives. This milestone reflects more than two decades of dedication by a global team of nearly 100 individuals who have positioned X-Therma at the cutting edge of #medicalinnovation. ?? Learn more about X-Therma's incredible breakthrough here: https://lnkd.in/gjwE4EqG Francesca Mongardi Guido Panizza Luca Salerno Maria Cristina Odasso Xiaoxi (Sofie) Wei Mark Kline Gerald Brandacher #Announcement #BioTech #ImpactInvesting #OrganTransplant #Healthcare #Innovation #XTherma